Mutation atembBCodon 306, a Potential Marker for the Identification of Multidrug Resistance Associated with Ethambutol in Mycobacterium tuberculosis
Open Access
- 1 September 2015
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (9) , 5455-5462
Abstract
Ethambutol inhibits arabinogalactan and lipoarabinomannan biosynthesis in mycobacteria. The occurrence of mutations in embB codon 306 in ethambutol-susceptible isolates and their absence in resistant isolates has raised questions regarding the utility of this codon as a potential marker for resistance against ethambutol. The characterization of mutations on embB 306 will contribute to a better understanding of the mechanisms of resistance to this drug; therefore, the purpose of this study was to investigate the association between embB 306 mutations and first-line drug resistance profiles in tuberculosis isolates. We sequenced the region surrounding the embB 306 codon in 175 tuberculosis clinical isolates, divided according to drug sensitivity, in three groups: 110 were resistant to at least one first-line drug, of which 61 were resistant to ethambutol (EMBr), 49 were sensitive to ethambutol (EMBs) but were resistant to another drug, and 65 were pansensitive isolates (Ps). The associations between embB 306 mutations and phenotypic resistance to all first-line drugs were determined, and their validity and safety as a diagnostic marker were assessed. One of the Ps isolates (1/65), one of the EMBs isolates (1/49), and 20 of the EMBr isolates (20/61) presented with an embB 306 mutation. Four different single-nucleotide polymorphisms (SNPs) at embB 306 were associated with simultaneous resistance to ethambutol, isoniazid, and rifampin (odds ratio [OR], 17.7; confidence interval [CI], 5.6 to 56.1) and showed a positive predictive value of 82%, with a specificity of 97% for diagnosing multidrug resistance associated with ethambutol, indicating its potential as a molecular marker for several drugs.Keywords
This publication has 38 references indexed in Scilit:
- SITVITWEB – A publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiologyInfection, Genetics and Evolution, 2012
- Assessing the utility of three TaqMan probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in Veracruz, MéxicoCanadian Journal of Microbiology, 2012
- Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, ChinaJournal of Antimicrobial Chemotherapy, 2011
- embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutationJournal of Antimicrobial Chemotherapy, 2010
- emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutolInternational Journal of Medical Microbiology, 2009
- Tuberculosis Drug Resistance Mutation DatabasePLOS Medicine, 2009
- Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and RifampinAntimicrobial Agents and Chemotherapy, 2008
- Association between embB Codon 306 Mutations and Drug Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Significance of Mutations in embB Codon 306 for Prediction of Ethambutol Resistance in Clinical Mycobacterium tuberculosis IsolatesAntimicrobial Agents and Chemotherapy, 2006
- Genetic Polymorphism inMycobacterium tuberculosisIsolates from Patients with Chronic Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2004